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Abstract A gene, CYPII9, for a potential cytochrome P450 
has been isolated and sequenced from the extreme acidothermo- 
philic archaeon Sulfolobus solfataricus. The gene predicts a 
polypeptide of 368 amino acids containing the consensus berne- 
binding sequence Phe-Gly-Xaa-Gly-Xaa-His-Xaa-Cys-Xaa-Gly- 
Xaa3-Ala-Arg-Xaa-Glu. It most closely resembles the cyto- 
chrome P450s found in the bacterium Bacillus subtilis, with 
which it shares 129 identical amino acid residues (35%). This 
first sequence of a potential archaeal cytochrome P450 
represents an important step in tracing the complex evolutionary 
history of this biologically important enzyme family. 
Key words: Cytochrome P450; Evolution; Archaea; 
Archaebacteria; CYP119 
1. Introduction 
Inc., Westboro, MA); restriction endonucleases, T4 DNA ligase, 
pGEM-3Z, Prime-a-Gene DNA labelling kit, and Erase-A-Base kit 
(Promega, Madison, WI); Sequenase version 2.0 DNA sequencing 
kit, pUC vectors, and shrimp alkaline phosphatase (US Biochemicals, 
Cleveland, OH); GeneAmp PCR core reagent kit (Perkin Elmer, 
Branchburg, NJ); E. coli DH5e~ cells (Life Technologies, Inc., 
Gaithersburg, MD); Long Ranger gel solution (J.T. Baker, Phillips- 
burg, NJ); and Deep Vent DNA polymerase (New England Biolabs, 
Beverly, MA). E. coli 7118 was the generous gift of Dr. Dennis Dean, 
Virginia Tech. All other eagents were purchased from Sigma Chemi- 
cal Co. (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA). 
2.2. Cloning procedures 
S. solfataricus (ATCC 35091) was grown, genomic DNA isolated 
therefrom, and genomic DNA libraries constructed as described by 
Leng et al. [4]. Restriction enzyme digests, Southern blots, and the 
identification and isolation of DNA clones were performed using 
standard procedures [5]. Oligonucleotide probes were radiolabelled 
with 32p using the Prime-A-Gene kit following the manufacturer's 
protocols. DNA sequencing was performed by the dideoxy method 
of Sanger et al. [6] using a Sequenase v rsion 2.0 kit following the 
manufacturer's protocol. 
The cytochrome P450s comprise a large family of heme- 
containing monooxygenases ubiquitously distributed among 
aerobic organisms (reviewed in [1-3]). These enzymes partici- 
pate in the oxidation of a wide range of endogenous and 
exogenous organic ompounds. While the oxidation of foreign 
substances by cytochrome P450 can serve as an important 
step in their neutralization, in man and other organisms the 
oxidation of foreign compounds often results in the creation 
of highly toxic and/or carcinogenic metabolites -- hence these 
enzymes have been the subject of intense scrutiny. The genes 
for several hundred cytochrome P450s have now been se- 
quenced. They suggest a complex evolutionary history that 
crosses phylogenetic divisions, an evolutionary history that 
is only partially understood [2,3]. One of the barriers to un- 
ravelling the chain of gene duplication, gene transfer, and 
other events is the lack of any data concerning the cyto- 
chrome P450s from the third phylogenetic domain, the Ar- 
chaea. Thus, when we accidentally encountered the partial 
clone of a gene predicting a potential cytochrome P450 
from the extreme acidothermophilic archaeon Sulfolobus sol- 
fataricus, we seized upon the opportunity to begin filling a 
major gap in the evolutionary history of this important en- 
zyme superfamily. 
2. Materials and methods 
2.1. Materials 
Purchased materials included custom oligonucleotides (DNAgency, 
Malvern, PA); radiochemicals (DuPont/New England Nuclear, Bos- 
ton, MA); nitrocellulose and nylon membranes (Micron Separations, 
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2.3. PCR techniques 
The following oligonucleotide primers were used for PCR: primer 
A, 5'-d(GGGAATTCCRTDTAYGGWVHHCARTGG)-3'; primer 
B, 5'-d(GGGATCCCSWHGCDATRTTRAANGG)-Y; primer C, 
5'-d(CCCGGATCCATTTATCTGAATTCCCAAGG)-3'; and pri- 
mer D (SP6 promoter primer), 5'-d(GATTTAGGTACACTATAG)- 
3'. 'Touchdown' PCR was performed by the procedure of Roux [7] as 
modified by Leng et al. [4]. The synthesis of the 920 bp primer was 
performed according to the standard PCR protocol of Leng et al. [4], 
with the exception that the quantity of DNA used was reduced from 
1000 to 500 ng and the quantity of each primer was increased from 
100 to 500 pmol. 
3. Results and discussion 
The gene for the potential archaeal cytochrome P450 was 
encountered during an attempt to isolate clones for a thymi- 
dylate synthase gene from the extreme acidophilic archaeon 
S. solfataricus. Briefly, touchdown PCR amplification of geno- 
mic DNA from S. solfataricus was performed using degener- 
ate oligonucleotide primers A and B, which were modelled 
after the sequence of thymidylate synthase from E. coli. The 
300 bp product that resulted was used to probe a genomic 
DNA library contained in plasmid pGEM-3Z that had been 
constructed using the restriction enzyme HindlII. Several po- 
tential clones were isolated and their ends sequenced. A com- 
puter search of DNA databases using the BLASTX program 
revealed that the 5'-end of one clone, = 1.5 kb in length, 
predicted a gene product possessing significant sequence 
homology to the members of the cytochrome P450 family. 
It also was apparent that it encoded only a portion of the 
presumed structural gene, specifically the first 294 amino 
acid residues of the protein. Using PCR primers C and D, a 
920 bp probe encompassing this partial clone was synthesized 
and utilized to probe a second library of S. solfataricus geno- 
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TAA ~ T  ATC GTA TTT TTT CTA TAT CTA TAC TTT AAG TTA AGA TAT ATC TAT TTA TTT 
ATC TGA AM'  CCC AAG GTA TTA CCT ATG TAT GAC TGG TTT AGT GAG ATG AGA AAG AAA GAC CCA GTG 
** *** *** ** M Y D W F S E M R KI0 K D P V 
TAT  TAT GAC GGA AAC ATA TGG CAG GTG TTT TCC TAT AGG TAC ACA AAG GAG GTT TTA AAC AAC TTT 
Y Y D G N I20 W Q V F S Y R Y T K30 E V L N N F 
TCG AAA TTC TCC TCA GAT CTT ACA GGT TAC CAC GAA AGG CTT GAG GAC CTA AGG AAC GGT AAA ATA 
S K F S $40 D L T G Y E E R !~50 E D L R N G K I 
AGG TTC GAC ATC CCC ACT AGG TAT ACC ATG CTG ACC TCA GAT CCC CCT CTC CAT GAT GAG TTA AGA 
R F60 D I P T R Y T M L T70 S D P P L H D E L Re0 
TCA ATG TCA GCA GAT ATA TTC TCG CCT CAA AAG CTA CAG ACA CTT GAG ACA TTT ATT AGG GAG ACC 
S M S A D I F S P Qg0 K L Q T L E T F I RI00 E T 
ACC AGA AGC CTA TTA GAC TCA ATT GAC CCT AGG GAA GAC GAC ATA GTG AAG AAG TTA GCT GTT CCA 
T R S L L D S Ili 0 D P R E D D I V K K120 L A V P 
CTA CCA ATA ATA GTT ATC TCA AAA ATA TTG GGT CTC CCA ATT GAA GAT AAG GAG AAG TTC AAA GAG 
L P I I V I130 S K I L G L P I E D140 K E K F K E 
TGG TCA GAC TTA GTC GCA TTC AGG TTG GGT AAG CCT GGA GAA ATA TTT GAG CTA GGT AAG AAG TAC 
W S D L150 V A F R L G K P G El60 I F E L G K K Y 
CTT GAG TTA ATA GGT TAT GTG AAG GAT CAT CTA AAT TCA GGG ACC GAA GTG GTC AGC AGA GTT GTC 
L E170 L I G Y V K D E L N180 S G T E V V S R V V190 
AAC TCA AAC CTC TCA GAC ATA GAG AAA CTC GGA TAC ATT  ATT  TTA CTT CTC ATA GCG GGT AAT GAG 
N S N L S D I E K L200 G Y I I L L L I A G210 N E 
ACT ACA ACT AAC TTA ATA TCA AAC TCT GTT ATT  GAC TTC ACT AGG TTT AAC CTG TGG CAG AGG ATA 
T T T N L I S N220 S V I D F T R F N L230 W Q R I 
AGG GAA GAG AAC CTC TAC CTT AAG GCT ATC GAA GAG GCT TTA AGG TAT TCT CCT CCT GTG ATG AGG 
R E E N L Y240 L K A I E E A L R Y250 S P P V M R 
ACT GTA AGA AAG ACT AAG GAA AGA GTG AAA TTG GGT GAT CAG ACT ATT GAA GAG GGA GAG TAC GTT 
T V R K260 T K E R V K L G D Q270 T I E E G E Y V 
AGA GTA TGG ATA GCC TCA GCA AAC AGG GAC GAG GAG GTG TTT CAT GAC GGA GAG AAG TTC ATC CCT 
R V280 W I A S A N R D E E290 V F H D G E K F I P300 
GAC AGG AAT CCG AAC CCA CAC TTA AGC TTT GGG TCT GGA ATA CAT CTG TGT TTA ~ GCT CCT TTG 
D R N P N P E L S F310 G S G I H L C L G A320 P L 
GCT AGA TTA GAG GCA AGA ATA GCA ATT GAG GAA TTT TCA AAA AGG TTT AGG CAC ATT  GAG ATA TTG 
A R L E A R I A330 I E E F S K R F R H340 I E I L 
GAT ACT GAA AAA GTT CCA AAT GAA GTG CTG AAT GGT TAT AAG AGA CTA GTG GTC AGG TTG AAG AGT 
D T E K V P350 N E V L N G Y K R L360 V V R L K S 
AAT GAA TAA TGC AGA GAG GTT TCT CCA CTT RAT GTT AAA GGA GGG AAG AAA GGT GTT ATT  TCT GTT 
N E end 
Fig. 1. Complete DNA and inferred amino acid sequence of S. solfataricus cytochrome P450. This sequence, along with portions of the 3' and 
5' untranslated regions not shown above for reasons of space, are listed in the GenBank Data Base under accession number U51337. 
mic DNA. This library was contained in plasmid pUC119 and strong resemblance to the members of the cytochrome P450 
had been constructed using the restriction enzyme XbaI. This family. 
resulted in the isolation of a =2.5 Kb fragment encoding the The open reading frame for the potential archaeal cyto- 
entire open reading frame for a potential protein possessing a chrome P450, CYP l l9 ,  predicts a polypeptide of 368 amino 
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Fig. 2. Comparison of the inferred amino acid of the archaeal cytochrome P450 with other members of the cytochrome P450 family. Shown is 
the derived amino acid sequence of S. solfataricus (S. solf.) cytochrome P450 aligned with the corresponding regions of cytochrome P450s from 
three bacteria: CYP109 from Bacillus subtilis (B. subt. [10]), CYP107A1 from Saccharopolyspora erythrea (S. eryth. [11]), and ORF1 from the 
fas locus in Rhodococcusfascians (Rh. fasc. [12]), and four eukaryotes: CYP55 from the fungus Fusarium oxysporum (Fus. ox. [13]), CYP3All 
from mouse (mouse [14]), CYP3A4 from human (human [15]), and CYP56 from the yeast Candida maltosa (yeast [16]). Sequences were aligned 
using the BLASTX program from the National Center for Biotechnology Information. Identities with the archaeal cytochrome P450 are en- 
closed by boxes. 
acids (Fig. 1). The first of the two potential N-terminal 
methionines, Met I and Met s, was assigned as the initiator 
methionine based on two factors. First, the codon for Met 1 
is located adjacent o a strong potential ribosome binding 
sequence, AAGGTAATTCC,  as is typically the case for 
many archaeal genes [8]. Second, the sequence between Met 1 
and Met s contains several amino acid residues conserved in 
other cytochrome P450s, most notably Phe 5, but also includ- 
ing Asp 3, Trp 4, and Glu 7 (Fig. 2). A sequence, AAACCATT-  
TAAA, bearing a strong resemblance to the consensus pro- 
moter sequence for sulfur-dependent, thermophilic archaeons, 
AAANNTTTAAA [8], is located 77 nucleotides upstream of 
the predicted initiator methionine. A potential consensus tran- 
scription termination sequence, TTATTTCT [9], lies in a pyr- 
imidine-rich region 48 bp downstream from the translation 
termination codon. 
The predicted protein product lacks any evidence of an N- 
terminal membrane targeting sequence. This, along with se- 
quence identity comparisons, indicates that it should be clas- 
sified as one of the soluble, 'prokaryotic' (sometimes called B 
type [3]) cytochrome P450s found in many bacteria nd some 
'simple' eukaryotes, e.g. CYP55 of the fungus Fusarium oxy- 
sporum (Fig. 2). Its closest known homolog is CYP109 from 
Bacillus subtilis, with which it shares 35% amino acid sequence 
238 
Table 1 
Sequence identity between S. solfataricus CYP119 and selected cytochrome P450s 
R.L. Wright et al.IFEBS Letters 384 (1996) 235-239 
Cytochrome P450 Organism Identities % identity 
CYP109 B. subtilis 129 35 
CYP107A1 S. erythrea 107 29 
ORF1 offas operon R. fascians 85 23 
CYP55 F. fascians 82 22 
CYP3A11 Mouse 70 19 
CYP56 C. maltosa 70 19 
CYP3A4 Human 68 18 
The number of amino acid identities observed between CYPll9 from S. solfataricus and the cytochrome P450s described in Fig. 2 are tabu- 
lated. Percent identity levels were calculated by dividing the number of identical amino acids by the total number of amino acids in the 
S. solfatarieus equence, 368. 
identity --  129 identical residues out of 368 (Table 1). CYP119 
possesses a complete consensus heme-binding sequence, Phe- 
Gly-Xaa-Gly-Xaa-His/Arg-Xaa-Cys-Xaa-Gly-Xaaz-Ala-Arg- 
Glu [1], centered around Cys 317 near the C-terminal end. This 
fact, and the observation that the area of resemblance be- 
tween the potential archaeal protein and a set of representa- 
tive cytochrome P450s (Fig. 2) is spread quite generally 
throughout i s sequence, suggests that the gene product very 
likely constitutes a functional enzyme. What might this func- 
tion be? At this point in time it is difficult to tell, however, it 
is noteworthy that in its natural habitat S. solfataricus - -  
which is an obligate aerobe --  obtains energy primarily via 
the oxidation of elemental sulfur to sulfuric acid. Cytochrome 
P450s are already known to participate in sulfoxide formation 
[1] and have been postulated to comprise part of nature's 
most ancient respiratory systems [3]. Hence, it is tempting to 
speculate that the potential product of this open reading 
frame might participate in this metabolically vital sulfur oxi- 
dation process. 
What can this archaeal gene sequence tell us about the 
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Fig. 3. Phylogenetic relationship of S. solfataricus cytochrome P450 
to representative bacterial and eukaryotic ytochrome P450s. This 
tree was constructed using the Lasergene computer program from 
DNASTAR, Inc. (Madison, WI) and includes all of the cytochrome 
P450s shown in Fig. 2. The abbreviations u ed are explained in the 
legend to Fig. 2. 
have ventured for the first time into the archaeal phylogenetic 
kingdom, the putative cytochrome P450 from S. solfataricus 
looks very much like any other prokaryotic ytochrome P450. 
In fact, construction of an abbreviated dendrogram contain- 
ing a few representative bacterial and eukaryotic ytochrome 
P450s fails to betray any evidence of its archaeal status (Fig. 
3). Like CYP55 from the fungus F. oxysporum, it groups 
among several bacterial cytochrome P450s as if it were derived 
from another bacterium rather than from an archaeon. Since 
the apparent lineage of this archaeal cytochrome P450 does 
not follow phylogeny, this suggests the occurrence of a hor- 
izontal gene transfer event. Two things seems apparent con- 
cerning the nature of this event. Since the Archaea do not 
contain subcellular compartments or organelles, acquisition 
cannot have proceeded via the incorporation of material 
from the genome of a bacterial endosymbiont i to its genome, 
as could have been possible for a eukaryote such as F oxy- 
sporum. Second, the first bifurcation in phylogeny is the se- 
paration of the Bacteria from the lineage that eventually gave 
rise to the Archaea nd Eukaryotes. Although this means that 
S. solfataricus and F. oxysporum are much more closely re- 
lated to each other than either is to any bacterium, CYP l l9  
and CYP55 do not cluster together - -  once again in defiance 
of phylogeny. This suggests the occurrence of one or more 
horizontal gene transfer events after the separation of the 
archaeal and eukaryotic lineages one from another. However, 
the specific partners involved and the direction of the transfer, 
bacterium to eukaryote, archaeon to bacterium, etc. remains 
cryptic. The addition of future cytochrome P450 genes from 
the Archaea should do much to resolve these issues. 
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